565 related articles for article (PubMed ID: 32385892)
1. Spatiotemporal Delivery of CRISPR/Cas9 Genome Editing Machinery Using Stimuli-Responsive Vehicles.
Cai W; Luo T; Mao L; Wang M
Angew Chem Int Ed Engl; 2021 Apr; 60(16):8596-8606. PubMed ID: 32385892
[TBL] [Abstract][Full Text] [Related]
2. Nanoscale metal-organic frameworks for the intracellular delivery of CRISPR/Cas9 genome editing machinery.
Zheng Q; Li W; Mao L; Wang M
Biomater Sci; 2021 Oct; 9(21):7024-7033. PubMed ID: 34378567
[TBL] [Abstract][Full Text] [Related]
3. Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing.
Zhang S; Shen J; Li D; Cheng Y
Theranostics; 2021; 11(2):614-648. PubMed ID: 33391496
[TBL] [Abstract][Full Text] [Related]
4. Stimulus-Responsive Smart Nanoparticles-Based CRISPR-Cas Delivery for Therapeutic Genome Editing.
Naeem M; Hoque MZ; Ovais M; Basheer C; Ahmad I
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681959
[TBL] [Abstract][Full Text] [Related]
5. Recent Updates of the CRISPR/Cas9 Genome Editing System: Novel Approaches to Regulate Its Spatiotemporal Control by Genetic and Physicochemical Strategies.
Allemailem KS; Almatroudi A; Rahmani AH; Alrumaihi F; Alradhi AE; Alsubaiyel AM; Algahtani M; Almousa RM; Mahzari A; Sindi AAA; Dobie G; Khan AA
Int J Nanomedicine; 2024; 19():5335-5363. PubMed ID: 38859956
[TBL] [Abstract][Full Text] [Related]
6. Smart Strategies for Precise Delivery of CRISPR/Cas9 in Genome Editing.
Hasanzadeh A; Noori H; Jahandideh A; Haeri Moghaddam N; Kamrani Mousavi SM; Nourizadeh H; Saeedi S; Karimi M; Hamblin MR
ACS Appl Bio Mater; 2022 Feb; 5(2):413-437. PubMed ID: 35040621
[TBL] [Abstract][Full Text] [Related]
7. Cationic Polymer-Mediated CRISPR/Cas9 Plasmid Delivery for Genome Editing.
Zhang Z; Wan T; Chen Y; Chen Y; Sun H; Cao T; Songyang Z; Tang G; Wu C; Ping Y; Xu FJ; Huang J
Macromol Rapid Commun; 2019 Mar; 40(5):e1800068. PubMed ID: 29708298
[TBL] [Abstract][Full Text] [Related]
8. Fast and Efficient CRISPR/Cas9 Genome Editing In Vivo Enabled by Bioreducible Lipid and Messenger RNA Nanoparticles.
Liu J; Chang J; Jiang Y; Meng X; Sun T; Mao L; Xu Q; Wang M
Adv Mater; 2019 Aug; 31(33):e1902575. PubMed ID: 31215123
[TBL] [Abstract][Full Text] [Related]
9. Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing.
Fang T; Cao X; Ibnat M; Chen G
J Nanobiotechnology; 2022 Aug; 20(1):354. PubMed ID: 35918694
[TBL] [Abstract][Full Text] [Related]
10. Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing.
Chin JS; Chooi WH; Wang H; Ong W; Leong KW; Chew SY
Acta Biomater; 2019 May; 90():60-70. PubMed ID: 30978509
[TBL] [Abstract][Full Text] [Related]
11. Near-infrared optogenetic engineering of photothermal nanoCRISPR for programmable genome editing.
Chen X; Chen Y; Xin H; Wan T; Ping Y
Proc Natl Acad Sci U S A; 2020 Feb; 117(5):2395-2405. PubMed ID: 31941712
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
Tadić V; Josipović G; Zoldoš V; Vojta A
Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
[TBL] [Abstract][Full Text] [Related]
13. Points of View on the Tools for Genome/Gene Editing.
Chuang CK; Lin WM
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576035
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in CRISPR/Cas9-Mediated Genome Editing in
Muramoto T; Iriki H; Watanabe J; Kawata T
Cells; 2019 Jan; 8(1):. PubMed ID: 30642074
[TBL] [Abstract][Full Text] [Related]
15. Delivering Cas9/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient 'hit-and-run' genome editing.
Lyu P; Javidi-Parsijani P; Atala A; Lu B
Nucleic Acids Res; 2019 Sep; 47(17):e99. PubMed ID: 31299082
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in Improving Gene-Editing Specificity through CRISPR-Cas9 Nuclease Engineering.
Huang X; Yang D; Zhang J; Xu J; Chen YE
Cells; 2022 Jul; 11(14):. PubMed ID: 35883629
[TBL] [Abstract][Full Text] [Related]
17. Delivery of CRISPR/Cas9 for therapeutic genome editing.
Xu X; Wan T; Xin H; Li D; Pan H; Wu J; Ping Y
J Gene Med; 2019 Jul; 21(7):e3107. PubMed ID: 31237055
[TBL] [Abstract][Full Text] [Related]
18. Strategies for nonviral nanoparticle-based delivery of CRISPR/Cas9 therapeutics.
Chen F; Alphonse M; Liu Q
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 May; 12(3):e1609. PubMed ID: 31797562
[TBL] [Abstract][Full Text] [Related]
19. A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing.
Finn JD; Smith AR; Patel MC; Shaw L; Youniss MR; van Heteren J; Dirstine T; Ciullo C; Lescarbeau R; Seitzer J; Shah RR; Shah A; Ling D; Growe J; Pink M; Rohde E; Wood KM; Salomon WE; Harrington WF; Dombrowski C; Strapps WR; Chang Y; Morrissey DV
Cell Rep; 2018 Feb; 22(9):2227-2235. PubMed ID: 29490262
[TBL] [Abstract][Full Text] [Related]
20. Integrating Combinatorial Lipid Nanoparticle and Chemically Modified Protein for Intracellular Delivery and Genome Editing.
Chang J; Chen X; Glass Z; Gao F; Mao L; Wang M; Xu Q
Acc Chem Res; 2019 Mar; 52(3):665-675. PubMed ID: 30586281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
